Related Experiment Video
Updated: Feb 19, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Mapping modifiable risk factors for incident epilepsy: a large prospective cohort study
Xi-Han Cui1, Yi Zhang1, Xiao-Yu He1
1Department of Neurology and National Center for Neurological Disorders, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China.
Identifying modifiable risk factors could prevent a significant portion of epilepsy cases. Addressing factors like long-standing disability and avoiding certain medications may lower epilepsy risk, especially in those genetically predisposed.
Area of Science:
- Neurology
- Epidemiology
- Genetics
Background:
- The etiology of epilepsy is not fully understood, necessitating research into modifiable risk factors for improved comprehension and prevention.
- Epilepsy affects a significant portion of the population, highlighting the need for effective preventative strategies.
Purpose of the Study:
- To systematically map modifiable risk factors associated with epilepsy using a large-scale prospective cohort.
- To evaluate the causal impact of identified risk factors and estimate the potential reduction in epilepsy burden.
Main Methods:
- Utilized UK Biobank data from over 400,000 adults, with 3,600 developing epilepsy over 15.4 years.
- Conducted an exposure-wide association study (EWAS) on 196 factors, followed by Mendelian randomization analyses for causality.
- Calculated population attributable fractions (PAF) to estimate the impact of risk factor modification on epilepsy prevalence.
Main Results:
- Identified 27 significant modifiable risk factors across six domains associated with epilepsy (13.8% of factors studied).
- Mendelian randomization supported a causal link between long-standing disability and epilepsy.
- Estimated that 27.7%-51.5% of epilepsy cases could be prevented by modifying these factors, with absence of sedative-hypnotic or opioid use being most impactful (PAF: 21.1%/11.0%).
Conclusions:
- A comprehensive approach to understanding epilepsy etiology is crucial.
- Prioritizing risk factor modification, stratified by age and genetic predisposition, can lead to precise and efficient epilepsy prevention strategies.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists

